| CASE REPORT |
|
| Year : 2022 | Volume
: 4
| Issue : 1 | Page : 31 |
|
|
Retrobulbar hemorrhage: A complication to remember
Ana Maria Guzman, Maria Alejandra Martinez-Ceballos, Jaime De La Hoz
Department of Ophthalmic Plastic Surgery, Fundación Oftalmologica Nacional; Universidad del Rosario, School of Medicine and health Sciences, Bogotá, Colombia
Correspondence Address:
Maria Alejandra Martinez-Ceballos
Calle 50 # 13-50, Bogotá
Colombia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/pajo.pajo_21_22
|
|
|
Retrobulbar hemorrhage (RBH) is an ophthalmological complication with the potential risk of irreversible blindness due to the compressive effect on the optic nerve. Cases of patients with a history of antiaggregation and/or anticoagulation therapy and RBH have been reported in the literature; ophthalmologists should keep this antecedent in mind and consider the risk–benefit of surgery while working in conjunction with the area of anesthesia to establish the times when medication is suspended or initiated. Similarly, early and timely identification of signs and symptoms related to this complication improves patients' visual prognosis. The following describes the case of a patient who had RBH associated with the use of antiplatelet therapy.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
